Produção Docente

URI Permanente para esta coleção

https://dspace.inc.saude.gov.br/handle/123456789/21

Navegar

Navegando Produção Docente por Assunto "Acesso Universal aos Serviços de Saúde"

Agora exibindo 1 - 1 de 1
  • Item
    Testing COVID-19 in Brazil: fragmented efforts and challenges to expand diagnostic capacity at the Brazilian Unified National Health System
    (Cadernos de Saúde Pública, 2021) Kameda, Koichi; Barbeitas, Mady Malheiros; Caetano, Rosângela; Löwy, Ilana; Oliveira, Ana Claudia Dias de; Corrêa, Marilena Cordeiro Dias Villela; Cassier, Maurice
    Since the first recorded case of COVID-19 on February 26, 2020, Brazil has seen an exponential growth in the number of cases and deaths. The national testing approach has been insufficient to correctly use this tool in the support of containing the epidemic in the country. In this communication, we discuss efforts and challenges to scale-up COVID-19 testing at the Brazilian Uni- fied National Health System (SUS). This communication presents the initial results of the research project created to investigate the political, industrial, technological, and regulatory aspects that may affect the diagnostic and test- ing capacity for COVID-19 in Brazil. The paper draws on the review of aca- demic literature, media publication, and collection of public data on tests pur- chase and regulation. It enlists initiatives to enhance PCR testing, national production and development of technologies, as well as regulatory measures to fast-track new tests. Our analysis indicates some points of reflection. Firstly, the lack of a consistent national strategy to fight COVID-19 exarcebated sup- ply problems of diagnostic components. If the country was eventually able to circumvent this situation, it still faces a more structural dependency on the importation of diagnostic components. Secondly, the discontinued funding and distribution of tests may have implied health policy fragmentation and the growing importance of local governments and non-state actors to fighting the epidemics within SUS. Finally, initiatives established since the second se- mester of 2020 have expanded the testing capacity at SUS. However, it has not been sufficient to control the progress of the epidemic in the country.